We Give Shareholders a Voice

NRx Pharmaceuticals, Inc. Information Request Form

Levi & Korsinsky, LLP has commenced an investigation into the fairness of the 2021 de-SPAC merger of NRx Pharmaceuticals Inc. (f/k/a Big Rock Partners Acquisition Corp.) (“NRXP” or the "Company") (NASDAQ: NRXP) . Shortly after the NRXP 2021 de-SPAC merger closed, NRXP stock began spiraling downwards. The NRXP de-SPAC merger investigation concerns this transaction unfairly harmed stockholders and whether all material facts were properly disclosed to stockholders.

To receive more information, please fill out the form.

Enter Your Details Below

This submission does not create an attorney-client relationship. We will keep you up to date with this investigation, and should this investigation evolve, we will contact you to discuss whether to establish an attorney client relationship at no cost to you.

Review our Privacy Policy